🇺🇸 FDA
Patent

US 12415845

Methods of producing T cell populations using hydroxycitric acid and/or a salt thereof

granted A61KA61K2239/31A61K2239/38

Quick answer

US patent 12415845 (Methods of producing T cell populations using hydroxycitric acid and/or a salt thereof) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Sep 16 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K2239/31, A61K2239/38, A61K2239/57, A61K31/194